DOKA — Dormakaba Holding AG Share News
0.000.00%
- CH₣2.17bn
- CH₣2.76bn
- CH₣2.87bn
Europe Research Roundup: Biomerieux, Dormakaba Holding AG, HSBC
Brief: Dormakaba And Scheidt & Bachmann To Work On Parking And Building Access Management
Dormakaba sees annual organic growth above mid-term target of 3% to 5% (updated)
Dormakaba sees full-year organic growth above mid-term target of 3% to 5%
Brief: Dormakaba Holding H1 Net Sales Up At CHF 1.42 Bln
Europe Research Roundup: Cosmo Pharmaceuticals NV, Dormakaba Holding AG, KPN
Europe Research Roundup: Cosmo Pharmaceuticals NV, Dormakaba Holding AG, KPN
Europe Research Roundup: Azelis Group, Bellway, Tate & Lyle
Dormakaba falls on limited guidance visibility, lower dividend
European shares bounce back ahead of inflation data
Dormakaba sees half-year organic growth of slightly above 3% to 5% (updated)
Dormakaba sees organic growth of slightly above 3% to 5% in H1
Brief: Dormakaba Holding FY Net Sales Up At CHF 2.76 Billion
Swiss stocks - Factors to watch on August 31
Jefferies names stocks most vulnerable to German gas rationing
Swiss stocks - Factors to watch on June 1
Brief: Dormakaba Holding Wins Tender For All State-Owned Norwegian Airports
Swiss stocks - Factors to watch on May 2
Jefferies names capital goods top picks as growth slows down